NVEC vs. AOSL: Which Small-Cap Chip Stock Is the Better Buy?
This article analyzes two small-cap chip stocks, NVE Corporation (NVEC) and Alpha and Omega Semiconductor (AOSL), to determine which is a better investment. While AOSL, a volume-driven power semiconductor supplier, has faced challenges due to cyclical market weakness, NVEC, specializing in spintronic products, demonstrates greater stability, profitability, and a stronger balance sheet. The analysis concludes that NVEC offers a more favorable risk-adjusted advantage due to its defensive business model and attractive valuation.
NVEC vs. AOSL: Which Small-Cap Chip Stock Is the Better Buy?
This article compares two small-cap chip stocks, NVE Corporation (NVEC) and Alpha and Omega Semiconductor (AOSL), to determine which is the better investment. While AOSL is a volume-driven power semiconductor supplier facing cyclical market weaknesses, NVEC operates in a specialized niche with a more stable and profitable business model. The analysis concludes that NVEC offers a risk-adjusted advantage due to its financial strength, stable profitability, and lower valuation, despite AOSL's potential for higher upside in a strong semiconductor recovery.
NVEC vs. AOSL: Which Small-Cap Chip Stock Is the Better Buy?
This article compares two small-cap chip stocks, NVE Corporation (NVEC) and Alpha and Omega Semiconductor (AOSL), to determine which is a better investment. While AOSL faces challenges from cyclical end-market weakness affecting PCs, smartphones, and data centers, NVEC benefits from a niche business model focused on spintronic sensors, providing stability and profitability. The analysis concludes that NVEC offers a better risk-adjusted advantage due to its financial strength, stable profitability, and lower valuation, contrasting with AOSL's higher volatility and dependence on a future market recovery.
Earnings call transcript: NVE Corp Q3 2026 sees 23% revenue rise, stock climbs
NVE Corporation reported a significant 23% year-over-year revenue increase in Q3 2026, with EPS meeting expectations at $0.70, leading to a 12.4% surge in its stock price. The growth was largely fueled by a 335% rise in contract R&D revenue and a 16% increase in product sales, despite a slight dip in gross margin. The company remains focused on expanding its presence in high-value markets such as medical devices and AI-driven factory automation, with continued investment in R&D and new product development.
Insider Sell: Daniel Baker Sells Shares of NVE Corp (NVEC)
Daniel Baker, President & CEO of NVE Corp (NVEC), sold 1,258 shares of the company on January 29, 2026. This transaction leaves him with 59,928 shares. The stock is considered modestly overvalued based on its GF Value, with a price-to-GF-Value ratio of 1.22.
Nve Corp CEO Baker sells $92957 in common stock By Investing.com
NVE Corp CEO Daniel A. Baker sold 1,258 shares of common stock in two transactions, totaling $92,957. These sales occurred on January 27, 2026, and January 29, 2026, leaving Baker with 59,928 shares. The company recently reported a 23% increase in revenue for Q3 fiscal 2026, with earnings per share rising to $0.70.
Nve Corp CEO Baker sells $92957 in common stock
NVE Corp's President and CEO, Daniel A. Baker, sold a total of 1,258 shares of common stock in two transactions, amounting to $92,957. These sales took place on January 27 and January 29, 2026, with stock prices ranging from $72.25 to $74.04 per share. Following these transactions, Baker directly owns 59,928 shares of the company, while NVE Corporation also reported a 23% revenue increase for Q3 fiscal 2026.
NVE Corp To Go Ex-Dividend On February 2nd, 2026 With 1 USD Dividend Per Share
NVE Corp (NVEC.US) is scheduled to go ex-dividend on February 2nd, 2026, with a dividend of 1 USD per share. Shareholders of record on the ex-dividend date will receive the payment on February 27th, 2026. The article also provides general definitions of cash and stock dividends, along with disclaimers regarding investment advice and tax implications.
NVE Corp (NVEC) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
NVE Corp (NVEC) demonstrated strong financial performance in Q3 2026, with a 23% increase in revenue and an 11% rise in net income. This growth was driven by a significant boost in both product sales and contract R&D revenue, alongside a reduction in operating expenses. The company also improved its manufacturing capabilities and strengthened its customer relationships, despite a slight decrease in gross margin and an increase in effective tax rate.
NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend
NVE Corporation (Nasdaq: NVEC) announced strong financial results for the third quarter of fiscal 2026, with revenue increasing by 23% to $6.22 million and net income rising by 11% to $3.38 million. The company attributed this growth to robust product sales and a significant increase in contract research and development revenue. NVE also declared a quarterly cash dividend of $1.00 per share payable on February 27, 2026, to shareholders of record as of February 2, 2026.
NVE Corporation (NASDAQ:NVEC) Q3 2026 Earnings Call Transcript
NVE Corporation reported a 23% increase in revenue and an 11% increase in earnings for Q3 fiscal 2026, driven by growth across product sales and contract R&D. The company highlighted the completion of a major equipment expansion to boost capacity for advanced spintronic devices, and continued strong partnerships, including a 2-year extension with Abbott Laboratories. Discussions also covered the potential for MRAM technology licensing and the company's focus on high-value markets like medical devices and AI-powered industrial automation.
Why NVE Corporation Popped Today
NVE Corporation's stock jumped 14.7% after reporting strong fiscal Q3 2026 earnings, including a 23% increase in sales and an 11% rise in earnings per share. While the company is profitable, boasts strong free cash flow, and offers a substantial dividend, the author expresses some reservation about its valuation, suggesting it's a company worth watching due to its niche technology and lack of Wall Street analyst coverage.
NVE Corporation (NVEC) Reports 23% Revenue Growth in Q3 2026 Earnings Call
NVE Corporation (NVEC) announced a 23% year-over-year revenue increase in Q3 2026, reaching $3.38 million, driven by strong product sales and a significant rise in contract R&D revenue. Despite this growth, gross margin decreased to 79% due to product mix and increased distributor sales, though operating expenses saw a 12% reduction. The company expects new equipment to be operational by March 31, 2026, enhancing production capacity and future competitiveness.
Earnings call transcript: NVE Corporation’s Q3 2026 revenue surges 23%
NVE Corporation reported a significant 23% year-over-year revenue increase and an 11% rise in EPS to $0.70 for Q3 fiscal 2026, driven by growth in product sales and contract R&D. Despite a decrease in gross margin, the company demonstrated cost efficiency and remains focused on high-value markets like medical devices and defense technology. NVE's executives are optimistic about future growth, leveraging new equipment and intellectual property, and expanding market visibility through trade shows.
NVE Corp reports 23% revenue jump in third quarter
NVE Corporation reported a significant 23% increase in total revenue for the third quarter ended December 31, 2025, reaching $6.22 million, driven by strong product sales and a substantial jump in contract research and development revenue. Net income also rose by 11% to $3.38 million. The company declared a quarterly cash dividend of $1.00 per share and attributed the success to broad-based growth across its revenue lines.
NVE: Overview of Fiscal Third Quarter Results
NVE Corp. has announced its financial results for the third quarter, reporting a net profit of $3.4 million and earnings of 70 cents per share. The nanotechnology firm achieved $6.2 million in revenue during this period. The article provides a concise overview of NVE's fiscal performance for the quarter.
NVE: Fiscal Q3 Earnings Snapshot
NVE Corp. (NVEC) reported a profit of $3.4 million in its fiscal third quarter. The nanotechnology company, based in Eden Prairie, Minnesota, achieved net income of 70 cents per share and posted revenue of $6.2 million for the period.
NVE: Overview of Fiscal Third Quarter Results
NVE Corp. has announced its financial results for the fiscal third quarter, reporting a net profit of $3.4 million, or 70 cents per share. The nanotechnology firm achieved $6.2 million in revenue during this period. The article provides a brief overview of these key financial figures.
Spintronics firm NVE lifts Q3 sales 23% and sends out $1 dividend
NVE Corporation reported a significant 23% increase in Q3 fiscal 2026 revenue, reaching $6.22 million, driven by growth in both product sales and contract research and development. Net income for the quarter rose by 11% to $3.38 million. The company also announced a quarterly cash dividend of $1.00 per share.
NVE Corp (NVEC.US) will release its earnings report after the market closes on January 21.
NVE Corporation (NVEC.US) is scheduled to release its earnings report after the market closes on January 21. Investors and analysts will be closely watching the report for insights into the company's financial performance.
NVE (NASDAQ:NVEC) Stock Price Passes Above 200-Day Moving Average - Here's What Happened
NVE Corporation (NASDAQ:NVEC) recently saw its stock price climb above its 200-day moving average, reaching $68.10. The company is set to host a conference call on January 21st to discuss its third-quarter results, which could serve as a near-term catalyst. While NVE pays a $4.00 annual dividend, its payout ratio is around 140%, and analysts currently hold a "Hold" rating on the stock.
Spintronics maker NVE to share quarter results on Jan 21 webcast call
NVE Corporation (Nasdaq: NVEC) announced it would release its financial results for the quarter ended December 31, 2025, on January 21, 2026, after market close. The company will host a quarterly conference call and webcast later that day at 4:00 p.m. Central Time to discuss the results. NVE specializes in spintronics technology, producing high-performance sensors and couplers.
NVE Corp Is Quietly Exploding – Is NVEC the Sleeper Tech Stock You’re Sleeping On?
NVE Corp (NVEC) is presented as a potential "sleeper tech stock" that is gaining quiet attention due to its focus on high-margin, niche semiconductor technologies like magnetic sensors and spintronics. The article highlights its profitability, specialized market, and low float, suggesting it's suitable for investors seeking deep hardware tech rather than mainstream, high-glamour investments. It advises investors to conduct thorough research on earnings trends, balance sheets, customer exposure, and valuation before considering NVEC for their portfolio.
Exploring 3 Undiscovered Gems in the US Market
This article highlights three "undiscovered gems" in the U.S. market: NVE Corporation (NVEC), Preformed Line Products Company (PLPC), and China Yuchai International (CYD). It provides an overview of each company's operations, financial performance, and growth potential, emphasizing strong fundamentals despite varying recent performance. The piece aims to guide investors looking for opportunities in the current dynamic market.
NVE Corp: Quiet Microcap, Strong Signal – What The Latest Moves In NVEC Really Tell Investors
NVE Corp (NVEC), a microcap specializing in spintronics and magnetic sensors, has seen its shares consolidate after a strong multi-month run. Despite recent slight declines and low trading volume, the company's clean balance sheet and niche market position suggest it's a patient, cash-rich compounder rather than a speculative play. Investors are advised to watch for fundamental alignment to the recent run-up, as the lack of Wall Street coverage means its valuation is driven more by fundamental investors than analyst targets.
NVE Corp: Quiet Microcap, Strong Signal – What The Latest Moves In NVEC Really Tell Investors
NVE Corp's (NVEC) shares have recently seen a mild pullback after a strong multi-month rally, prompting investors to question if it's a healthy pause or a deeper reset. Despite its microcap status and thinly traded shares, NVEC has delivered respectable returns for long-term holders, driven by quiet accumulation rather than speculative frenzy. The company, which specializes in spintronics and magnetic sensors, remains largely under the radar of major financial analysts, making its movements more reflective of fundamental investor sentiment and insider activity.
NVE Corporation's (NASDAQ:NVEC) Share Price Could Signal Some Risk
NVE Corporation (NASDAQ:NVEC) has a high P/E ratio of 22.3x compared to the broader U.S. market average below 19x, which could indicate a potential risk. This high P/E is particularly concerning given that the company's earnings have declined by 14% over the last year and 21% over the last three years, significantly underperforming the market's expected growth. Investors appear overly bullish despite the unfavorable earnings trend, suggesting the current stock prices might not be sustainable.
NVE Corporation's (NASDAQ:NVEC) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
NVE Corporation's stock has risen 12% in the past month, prompting a closer look at its financial indicators, particularly its Return on Equity (ROE). While NVE exhibits a respectable ROE of 23% and positive earnings growth, its very high payout ratio (113%) suggests a potential issue with reinvestment for future growth. The article questions the sustainability of its momentum given its low earnings retention despite strong returns.
NVE (NASDAQ:NVEC) Shares Cross Above Two Hundred Day Moving Average - Here's Why
NVE Corporation (NASDAQ:NVEC) saw its shares cross above their 200-day moving average, trading as high as $74.05 on Tuesday before settling at $71.27. The company pays a quarterly dividend of $1.00, yielding 5.6%, but its dividend payout ratio is high at 140.35%. Analysts currently hold a consensus "Hold" rating for NVE, which has a market capitalization of $344.95 million.
NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend
NVE Corporation (Nasdaq: NVEC) announced its financial results for the quarter ended September 30, 2025, with total revenue decreasing 6% year-over-year to $6.35 million, primarily due to a significant decrease in contract research and development revenue. Despite this, the company reported a 4% sequential increase in revenue, driven by strong distributor and non-defense sales. NVE also declared a quarterly cash dividend of $1.00 per share payable on November 28, 2025.
NVE Corp Reports Y/Y Declines in Profit & Revenues in Q2
NVE Corporation experienced year-over-year declines in profit and revenues for Q2 fiscal 2026, primarily due to a significant drop in contract R&D revenues and a less profitable product mix. Despite these challenges, the company saw sequential revenue growth and is strategically shifting focus towards medical devices, industrial automation, and robotics markets, supported by new manufacturing equipment and a healthy sales pipeline. Management anticipates continued growth and profitability in the upcoming quarters.
NVE Corporation (NVEC): Net Margin Decline Challenges Steady Earnings Narrative
NVE Corporation (NVEC) reported a dip in net profit margin to 55.8% and negative earnings growth, challenging its historical "steady eddy" reputation despite averaging 5% annual growth over five years. The stock trades at a P/E of 25.2x, a discount to peers but a premium to its estimated fair value of $31.84, suggesting market confidence in its technological moat. Investors face a decision between attractive value signals and recent profitability reversals, prompting a closer look at long-term trends and potential operational adjustments.
NVE Corp Reports Q2 Fiscal 2026 Earnings: EPS at $0.68, Revenue at $6.35 Million
NVE Corp reported its Q2 fiscal 2026 earnings, showing a 6% decline in total revenue to $6.35 million and an 18% drop in net income to $3.31 million ($0.68 per diluted share). The decrease was primarily due to a 68% fall in contract research and development revenue, despite a modest 1% increase in product sales. The company announced a quarterly cash dividend of $1.00 per share, demonstrating a commitment to shareholder returns amidst challenges in revenue streams.
NVE Corp (NVEC.US) will release its earnings report after the market closes on October 22. - 富途牛牛
NVE Corp (NVEC.US) is scheduled to release its earnings report after the market closes on October 22. The article provides the company's previous quarterly financial performance, including revenue, net profit, and earnings per share for Q1 2026 and Q2 2025. Investors are advised to stay tuned for the upcoming report and potential earnings conference call.
NVE Corp (NVEC.US) will release its earnings report after the market closes on October 22.
NVE Corp (NVEC.US) is scheduled to release its earnings report after the market closes on October 22. The article provides a look at the company's previous financial performance, including revenue, net profit, and earnings per share for Q1 2025 and Q2 2024. Investors are advised to stay tuned for the upcoming report.
NVE Schedules Conference Call on Second Quarter Results - 01net
NVE Corporation announced its plan to release second-quarter financial results for the period ending September 30, 2025, on Wednesday, October 22, 2025, after market close. The company will host a conference call on the same day at 4:00 p.m. Central Time to discuss these results. Attendees can join via webcast or by dialing in, with an option to ask questions.
Oct. 22 Q2 2025 Results After Close — NVE Schedules 4:00 PM CT Conference Call and Webcast - Stock Titan
NVE Corporation (Nasdaq: NVEC) announced it will release its financial results for the quarter ended September 30, 2025, on Wednesday, October 22, 2025, after market close. The company will host a conference call and webcast on the same day at 4:00 p.m. Central Time to discuss the results. NVE is a leader in spintronics, manufacturing high-performance spintronic products.
NVE Corporation (NASDAQ:NVEC) is largely controlled by institutional shareholders who own 83% of the company
The provided content is a privacy consent dialog from Yahoo and does not contain an article about NVE Corporation. It discusses Yahoo's use of cookies and personal data for various purposes, allowing users to accept, reject, or manage their privacy settings.
Most Shareholders Will Probably Agree With NVE Corporation's (NASDAQ:NVEC) CEO Compensation
NVE Corporation's CEO, Daniel Baker, received total compensation of US$587k for the year to March 2025, which is 64% less than the industry average for similar-sized semiconductor companies. While the company's EPS declined and revenue dropped, shareholders have seen a 40% return over three years. Despite a lack of recent earnings growth, the CEO's compensation appears reasonable compared to industry peers, and his significant share ownership indicates alignment with company success.
NVE Corp Reports Q4 EPS of $0.80 and Revenue of $7.27 Million, H
NVE Corp reported a 3% increase in Q4 revenue to $7.27 million and a 2% increase in net income to $3.89 million ($0.80 per diluted share), driven by a significant rise in contract R&D revenue. However, the company experienced a 13% decline in fiscal year 2025 revenue to $25.9 million and a 12% drop in net income, largely due to decreased product sales. Despite challenges in product sales, the substantial growth in contract research and development highlights NVE Corp's efforts to diversify revenue and adapt to the semiconductor industry.
NVE: Fiscal Q3 Earnings Snapshot
NVE Corp. reported a net income of $4.2 million for its fiscal third quarter. The nanotechnology company, based in Eden Prairie, Minnesota, also announced a profit of 87 cents per share and revenue of $6.8 million for the period. The earnings report was generated by Automated Insights using data from Zacks Investment Research.
Biotricity and Mobile Cardiac Telemetry (MCT)
This article evaluates Biotricity (OTCMKTS:BTCY), an OTC company developing mobile cardiac telemetry (MCT) devices, highlighting its experienced co-founder and CEO, Waqaas Al-Siddiq, and the potential for AI in EKG interpretation. It discusses Biotricity's progress towards FDA clearance for its Bioflux solution hardware, emphasizing the importance of this approval for market rollout. The piece also notes the unusual presence of institutional investors despite its OTC status and the company's efforts to uplist to a major exchange.
Raging Capital Management and Trigran Investment’s Latest Moves
Raging Capital Management initiated a new position in Ply Gem Holdings Inc (NYSE:PGEM) with 3.59 million shares, making it the largest institutional shareholder. Meanwhile, Trigran Investments trimmed its stake in NVE Corp (NASDAQ:NVEC) by selling 28,869 shares, though it remains the largest institutional investor in the company. These moves highlight contrasting strategies by the two investment firms in these companies.
